Clinical Trials Logo

Bruxism clinical trials

View clinical trials related to Bruxism.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05760482 Active, not recruiting - Anxiety State Clinical Trials

Evaluation of the Relationship Between Bruxism and Tryptophan Metabolites

Start date: September 4, 2023
Phase: N/A
Study type: Interventional

Psychological causes are often cited as the most important of the underlying factors for bruxism. However, there are very few studies that can objectively demonstrate this. There are studies that are generally based on subjective data, that is, on questionnaires that indicate anxiety or stress. Recent studies have shown that tryptophan and its metabolites are associated with psychological health. In this study, researchers will measure the serum values of metabolites in the tryptophan pathway. Also, researchers will observe whether these metabolite levels differ significantly in patients with and without bruxism.

NCT ID: NCT03713827 Active, not recruiting - Bruxism Clinical Trials

Clinical Performance of a Glass Hybrid Restorative in NCCL's of Patients With Bruxism

Start date: March 2016
Phase: N/A
Study type: Interventional

This is a double blinded, split mouth, randomized clinical study that evaluated the performance of a glass hybrid restorative material in non-carious servical lesions in patients with bruxism. The lesions were restored with glass hybrid restorative (Equia Forte) or nano ceramic composite resin (Ceram-x One). Restorations were evaluated after 24 months according to USPHS criteria and the data were evaluated.

NCT ID: NCT02870543 Active, not recruiting - Nocturnal Bruxism Clinical Trials

Efficacy of Phytolacca Decandra and Melissa Officinalis in Children With Nocturnal Bruxism

Start date: September 2014
Phase: Phase 3
Study type: Interventional

This study aims to evaluate, through a crossover, controlled, double-blind and randomized clinical trial, the efficacy of Phytolacca decandra in association or not with Melissa officinalis in the treatment of children with nocturnal bruxism. Children from 3 to 12 years old with nocturnal bruxism will be randomly allocated into different groups of treatment stage as follows: (1) placebo; (2) Phytolacca decandra; (3) Melissa officinalis; (4) Phytolacca decandra associated with Melissa officinalis. All children will participate to each clinical stage, with a period of 14 days of whashout. Children and the principal investigator will be masked to treatment. The efficacy will be evaluated through parents report about the absence of tooth clenching or grinding by children and electromiography exams. The secondary outcomes that will be evaluated are: trait anxiety and quality of life related to oral health.

NCT ID: NCT01778881 Active, not recruiting - Bruxism Clinical Trials

Physical Therapy Interventions Relative to Dental Treatment in Individuals With Bruxism

Bruxism
Start date: March 2013
Phase: N/A
Study type: Interventional

Bruxism is a parafunctional habit characterized by grinding and/or clenching of the teeth. It may happen while awake (awake bruxism) or while sleeping (sleep bruxism). In adults, the prevalence is 20% for the awake bruxism and 8% for the sleep bruxism. Peripheral, central, and psychosocial factors influence the disorder, which may predispose to pain in the masticatory muscles and neck, headache, decreased pain thresholds in the masticatory and cervical muscles, limitation mandibular opening, sleep disorders, stress, anxiety, depression, and overall impairment of oral health. The aim of this study is to compare physical therapy interventions with dental treatment in pain, mandibular opening, sleep quality, anxiety, stress, depression, and oral health in individuals with bruxism.